Meet with us at World Orphan Drug Congress Europe!
Join Premier Research at the World Orphan Drug Congress Europe in the Netherlands, where global leaders in rare disease, orphan drug development, advanced therapies, and patient advocacy come together to shape the future of healthcare innovation.
Premier Research partners with biotechnology and pharmaceutical organizations to accelerate the development of rare disease therapies through flexible, scientifically driven clinical development solutions. Our expertise spans clinical operations, regulatory strategy, biometrics, medical affairs, patient engagement, and global trial execution.
Whether you’re advancing an orphan drug, gene therapy, cell therapy, or another innovative treatment, our team is ready to help navigate the unique challenges of rare disease development and bring life-changing therapies to patients faster.
Featured Presentation: Building Readiness for FDA Accelerated Approval in Rare Disease Development
- Date: 27 October 2026 | 3:10 – 3:40 PM
- Speaker: Jaclyn (Jackie) Brown, Project Delivery, Rare Disease & Pediatrics
- Understand the fundamentals of FDA accelerated approval within a global development strategy
- Prioritize early activities that can reduce downstream risk and strengthen approval readiness
- Explore real-world examples of how rare disease programs have prepared for inspections and navigated accelerated approval requirements
On-Site
- Jackie Brown, Vice President, Project Delivery, Specialty Areas
- Adam Bloomfield Vice President Medical Affairs
- Corinne Blanchet, Executive Director, Program Delivery
- Christine Tiesler, Executive Director, Program Delivery
- Duncan Ibbs, Executive Director, Business Development
- Veronica Yildirim, Director, Business Development
Fill out the form above to schedule a meeting with our on-site team.
Connect with our team on site to discuss your rare disease development needs.
